Top Part time Masters in Pharmaceutical Science 2019/2020 in Europe
A master’s degree is an advanced study program that can be completed in about two years, provided students have already earned a bachelor’s degree in a similar area. Students can choose to earn a Master of Arts, an MSc, or an MBA, depending on their current and future goals.
The study of pharmaceutical science focuses on drug development, manufacturing and delivery, which is important to understanding how to improve drugs to better combat human disease. Pupils may tailor their education to their interests, and may study chemical and biochemical engineering, molecular biology, physiology and pharmacology.
Master Part time in Pharmaceutical Science in Europe
5 Results in Pharmaceutical Science, Europe Filter
The Master is aimed at graduates or graduates in Pharmacy, Medicine, Veterinary Biology, as well as any other Diploma or Degree in related areas such as chemistry, biochemistry and biotechnology.
This programme is taught as either a classic one-year programme or delivered through blended e-learning on a two-year part-time basis. The degree builds on Pfizer Ltd's 'in-house' training programme. It teaches how fundamental science is applied to the discovery and development of medicines. The programme was designed and conceived by industry experts in drug discovery and will be delivered and assessed by subject matter experts from both industry and the university.
The aim of our Master’s Degree in Pharmaceutical Chemistry is to train professionals and researchers with a profile applied to research and development of products, processes, and services in different industrial areas related to pharmaceutical chemistry.
Master of Medicines Regulatory Affairs is a continuing education programme targeted at professionals in the pharmaceutical industry. Admission requires a minimum of two years of relevant work experience.
Master of Industrial Drug Development is designed to meet the need for managers to coordinate the many elements involved in order to accelerate the drug development process and smooth the transition of candidate drugs to market.